Literature DB >> 16545541

Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications.

Martin Debbané1, Bronwyn Glaser, Melissa K David, Carl Feinstein, Stephan Eliez.   

Abstract

Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk for developing schizophrenia: half of affected adolescents report transient psychotic experiences and up to 30% of adults are diagnosed with schizophrenia. Prospective studies have shown that psychotic symptoms in childhood are predictive of later schizophreniform disorders. The current study aimed to define the prevalence and correlates of psychotic symptoms (PS) in young children and adolescents with 22q11DS. Forty-three children and adolescents with 22q11DS (mean age = 10.62+/-11.19) participated in this study. The occurrence of PS and their neuropsychological and behavioral correlates were investigated through semi-structured interviews and standardized measures. Psychotic symptoms were reported in 28% of the total sample and 17% of pre-adolescent children, and associated with decreased verbal IQ scores [F(1) = 4.41, p = 0.042]. Compared to young patients without PS, young patients with PS were perceived by their parents as more anxious-depressed [F(1) = 4.76, p = 0.035] and withdrawn [F(1) = 7.63, p = 0.009], with reduced adaptive socialization skills [F(1) = 6.88, p = 0.012]. Results suggest that psychotic manifestations are present earlier than typically reported in youngsters with 22q11DS and are accompanied by reduced verbal IQ performance and decreased adaptative social skills. The symptomatic, neuropsychological and behavioral characteristics observed in the current study may constitute central markers of increased risk for psychosis in 22q11DS.

Entities:  

Mesh:

Year:  2006        PMID: 16545541     DOI: 10.1016/j.schres.2006.01.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  49 in total

Review 1.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

Review 2.  The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan.

Authors:  Rachel K Jonas; Caroline A Montojo; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

3.  Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the intervention.

Authors:  V Shashi; W Harrell; S Eack; C Sanders; A McConkie-Rosell; M S Keshavan; M J Bonner; K Schoch; S R Hooper
Journal:  J Intellect Disabil Res       Date:  2015-04-14

Review 4.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

5.  Commentary on Treatment Resistant Psychosis in an adolescent with scoliosis and a history of early feeding difficulties.

Authors:  Andrea Stachon
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-02

Review 6.  The genomics of schizophrenia: update and implications.

Authors:  Paola Giusti-Rodríguez; Patrick F Sullivan
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

Review 7.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

8.  Anxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series.

Authors:  Andrea C Stachon; Claire De Souza
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-11

Review 9.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Tara Niendam; Robert Hendren; Cameron Carter; Tony J Simon
Journal:  Schizophr Res       Date:  2010-01-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.